Detailed Information for S00046

Basic information about inhibitors

IPAD-DB ID S00046
Name 4-(3-(Piperidin-1-yl)propoxy)-7H-dibenzo[de, h]quinolin-7-one
Category Synthetic compounds
2D Structure
3D Structure
Molecular Formula C 2 4 H 2 4 N 2 O 2
Molecular Weight 372.5 g/mol
IUPAC Name 12-(3-piperidin-1-ylpropoxy)-16-azatetracyclo[7.7.1.02, 7.013, 17]heptadeca-1(16), 2, 4, 6, 9(17), 10, 12, 14-octaen-8-one
InChI InChI=1S/C24H24N2O2/c27-24-18-8-3-2-7-17(18)23-22-19(11-12-25-23)21(10-9-20(22)24)28-16-6-15-26-13-4-1-5-14-26/h2-3, 7-12H, 1, 4-6, 13-16H2
InChIKey AQQCKOMUSAPZEU-UHFFFAOYSA-N
Canonical SMILES C1CCN(CC1)CCCOC2=C3C=CN=C4C3=C(C=C2)C(=O)C5=CC=CC=C54
PubChem CID 52953209
DrugBank Accession Number -
CAS Registry Number -

Biological activity data

Ki -
EC50
IC50 22±1 nM(AChE), 905±16 nM(BCHE)
Inhibition 42.97%(Aβ1-42 aggregation)
Toxicity
ROS(reactive oxygen species)
Metal Chelating
BBB(blood-brain barrier)
Target Protein Aβ1-42
Effects Inhibit AChE and BCHE and have good inhibition for Aβ1-42 aggregation
Research Models In SH-SY5Y cell, docking study, in vitro
Ref. Link

Physicochemical properties

Molecular Weight(Computed by SwissADME) 372.46
Hac(Computed by SwissADME) 28
Volume(Computed by ADMETlab 2.0) 396.724
Density(Computed by ADMETlab 2.0) 0.938
nRing(Computed by ADMETlab 2.0) 5
MaxRing(Computed by ADMETlab 2.0) 16
nHet(Computed by ADMETlab 2.0) 4
fChar(Computed by ADMETlab 2.0) 0
nRig(Computed by ADMETlab 2.0) 27
Flexibility(Computed by ADMETlab 2.0) 0.185
Stero Centers(Computed by ADMETlab 2.0) 0
LogS(Computed by ADMETlab 2.0) -5.627
LogD(Computed by ADMETlab 2.0) 3.558

ADMET properties

logP(Computed by ADMETlab 2.0) 4.871
TPSA(Computed by SwissADME) 42.43
Hbond Acceptor(Computed by SwissADME) 4
Hbond Donor(Computed by SwissADME) 0
Rotatable Bonds(Computed by SwissADME) 5

Pharmacokinetics

GI Absorption(Computed by SwissADME) High
BBB(blood-brain barrier) Permeant(Computed by SwissADME) Yes
P-gp Substrate(Computed by SwissADME) Yes
CYP1A2 Inhibitor(Computed by SwissADME) Yes
CYP2C19 Inhibitor(Computed by SwissADME) No
CYP2C9 Inhibitor(Computed by SwissADME) Yes
CYP2D6 Inhibitor(Computed by SwissADME) Yes
CYP3A4 Inhibitor(Computed by SwissADME) Yes
log Kp(Skin Permeation)(Computed by SwissADME) -5.38

Druglikeness

Lipinski(Computed by SwissADME) 0
Ghose(Computed by SwissADME) 0
Veber(Computed by SwissADME) 0
Egan(Computed by SwissADME) 0
Muegge(Computed by SwissADME) 0
Bioavailability Score(Computed by SwissADME) 0.55